|
TCTE3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.579720E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.695500E-02 |
| Normal-vs-Stage2 |
1.194230E-01 |
| Normal-vs-Stage3 |
4.643400E-01 |
| Normal-vs-Stage4 |
3.421600E-01 |
| Stage1-vs-Stage2 |
3.962800E-01 |
| Stage1-vs-Stage3 |
3.819200E-01 |
| Stage1-vs-Stage4 |
5.796200E-01 |
| Stage2-vs-Stage3 |
2.308200E-01 |
| Stage2-vs-Stage4 |
9.208400E-01 |
| Stage3-vs-Stage4 |
4.471000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.903700E-02 |
| Normal-vs-AfricanAmerican |
3.056500E-02 |
| Normal-vs-Asian |
9.520200E-01 |
| Caucasian-vs-AfricanAmerican |
6.025000E-01 |
| Caucasian-vs-Asian |
4.399200E-01 |
| AfricanAmerican-vs-Asian |
4.085600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.835660E-02 |
| Normal-vs-Female |
5.787900E-02 |
| Male-vs-Female |
9.673400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.035150E-01 |
| Normal-vs-Extreme_Weight |
1.977210E-01 |
| Normal-vs-Obese |
2.326200E-02 |
| Normal-vs-Extreme_Obese |
1.878390E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.177400E-01 |
| Normal_Weight-vs-Obese |
8.772400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.796800E-01 |
| Extreme_Weight-vs-Obese |
1.895570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.872600E-01 |
| Obese-vs-Extreme_Obese |
6.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.012200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.798100E-03 |
| Normal-vs-Age(61-80Yrs) |
8.619600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.039200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.851400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.985800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.624300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.961800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.675000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.879430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.845700E-04 |
| Normal-VS-Type2 PRCC |
6.732600E-01 |
| Normal-VS-KIRP CIMP |
1.404840E-01 |
| Normal-VS-Unclassified PRCC |
4.569200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.62410000000124E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.702000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.110000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.908620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.608400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.752000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.206000E-01 |
| Normal-vs-N1 |
2.022000E-01 |
| Normal-vs-N2 |
2.136600E-01 |
| N0-vs-N1 |
4.468000E-01 |
| N0-vs-N2 |
1.652410E-01 |
| N1-vs-N2 |
1.563760E-02 |
|
|
